Search by PDB author

Human Plasma Coagulation FXI with peptide LP2
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose, Coagulation factor XI, LP2
Authors:	Wong, S.S, Ostergaard, S, Hall, G, Li, C, Williams, P.M, Stennicke, H, Emsley, J.
Deposit date:	2015-11-10
Release date:	2016-04-06
Last modified:	2020-07-29
Method:	X-RAY DIFFRACTION (3.1 Å)
Cite:	A novel DFP tripeptide motif interacts with the coagulation factor XI apple 2 domain. Blood, 127, 2016

Human Plasma Coagulation Factor XI in complex with peptide P39
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, Coagulation factor XI, ...
Authors:	Wong, S.S, Ostergaard, S, Hall, G, Li, C, Williams, P.M, Stennicke, H, Emsley, J.
Deposit date:	2015-11-10
Release date:	2016-04-06
Last modified:	2020-07-29
Method:	X-RAY DIFFRACTION (2.8 Å)
Cite:	A novel DFP tripeptide motif interacts with the coagulation factor XI apple 2 domain. Blood, 127, 2016

human recombinant coagulation FXI in complex with a peptide derived from human high molecular weight kininogen (HKP)
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose, ASN-PRO-ILE-SER-ASP-PHE-PRO-ASP, Coagulation factor XI
Authors:	Hall, G.A.F, Wong, S.S, Emsley, J.
Deposit date:	2016-02-08
Release date:	2016-04-06
Last modified:	2020-07-29
Method:	X-RAY DIFFRACTION (2.85 Å)
Cite:	A novel DFP tripeptide motif interacts with the coagulation factor XI apple 2 domain. Blood, 127, 2016

The metal ion-dependent adhesion site (MIDAS) of the alphaMbeta2 integrin Mac-1 I-domain promiscuously and competitively binds multiple ligands in the regulation of Leukocyte function
Descriptor:	2-(N-MORPHOLINO)-ETHANESULFONIC ACID, DI(HYDROXYETHYL)ETHER, GLYCEROL, ...
Authors:	Emsley, J, Saleem, M.
Deposit date:	2017-09-24
Release date:	2018-10-24
Last modified:	2024-01-17
Method:	X-RAY DIFFRACTION (2 Å)
Cite:	Structural basis of the leukocyte integrin Mac-1 I-domain interactions with the platelet glycoprotein Ib. Blood Adv, 3, 2019